Patents by Inventor Allan Olson

Allan Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12559311
    Abstract: An earthquake restraint grid framework structure includes a grid framework structure for supporting a load handling device operative to move one or more containers in a stack. The grid framework structure includes intersecting grid members arranged to form a grid having plural f substantially rectangular frames in a horizontal plane, each of the substantially rectangular frames constituting a grid cell. The grid is supported by plural upright columns at each of the intersections of grid members to form a plurality of vertical storage locations for containers to be stacked between the upright columns and be guided in a vertical direction through the substantially rectangular frames. An exoskeleton includes plural vertical frame columns braced by at least one bracing member, the grid being further supported by the exoskeleton to form a seismic restraint system (SFRS).
    Type: Grant
    Filed: March 2, 2021
    Date of Patent: February 24, 2026
    Assignee: Ocado Innovation Limited
    Inventors: Olivier Phaneuf, Nicholas Mclarney, Robert Pallmann, Allan Olson, Scott Emmett, Neil Carstairs, Steven Craig, Enrique Rodal, Aditya Dwivedi
  • Patent number: 12462597
    Abstract: A fingerprint sensor, comprising fingerprint sensing circuitry configured to sense a fingerprint of a finger, and to provide a representation of the fingerprint; a sensor interface coupled to the fingerprint sensing circuitry, and comprising at least a first input pad for input to the fingerprint sensor of at least a first digital signal, and at least one output pad for output from the fingerprint sensor of a digital data signal encoding the representation of the fingerprint; and IO-voltage determining circuitry coupled to the first input pad and configured to sense a voltage level of the first digital signal, and to determine, based on the sensed voltage level of the first digital signal, a nominal voltage level to use for the digital data signal encoding the representation of the fingerprint.
    Type: Grant
    Filed: May 5, 2023
    Date of Patent: November 4, 2025
    Assignee: FINGERPRINT CARDS ANACATUM IP AB
    Inventors: David Carling, Allan Olson, Hans Thörnblom
  • Publication number: 20250285463
    Abstract: A fingerprint sensor, comprising fingerprint sensing circuitry configured to sense a fingerprint of a finger, and to provide a representation of the fingerprint; a sensor interface coupled to the fingerprint sensing circuitry, and comprising at least a first input pad for input to the fingerprint sensor of at least a first digital signal, and at least one output pad for output from the fingerprint sensor of a digital data signal encoding the representation of the fingerprint; and IO-voltage determining circuitry coupled to the first input pad and configured to sense a voltage level of the first digital signal, and to determine, based on the sensed voltage level of the first digital signal, a nominal voltage level to use for the digital data signal encoding the representation of the fingerprint.
    Type: Application
    Filed: May 5, 2023
    Publication date: September 11, 2025
    Inventors: David Carling, Allan OLSON, Hans THÖRNBLOM
  • Publication number: 20240425582
    Abstract: The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an interleukin-13 (IL-13) antibody, or an antigen binding fragment, thereof.
    Type: Application
    Filed: September 9, 2024
    Publication date: December 26, 2024
    Applicant: AbbVie, Inc.
    Inventors: Gregg Timony, Sheila Gujrathi, Robert Peach, Allan Olson
  • Patent number: 12129294
    Abstract: The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an interleukin-13 (IL-13) antibody, or an antigen binding fragment, thereof.
    Type: Grant
    Filed: February 3, 2023
    Date of Patent: October 29, 2024
    Assignee: AbbVie Inc.
    Inventors: Gregg Timony, Sheila Gujrathi, Robert Peach, Allan Olson
  • Patent number: 12122826
    Abstract: The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an interleukin-13 (IL-13) antibody, or an antigen binding fragment, thereof.
    Type: Grant
    Filed: May 10, 2022
    Date of Patent: October 22, 2024
    Inventors: Gregg Timony, Sheila Gujrathi, Robert Peach, Allan Olson
  • Publication number: 20230220061
    Abstract: The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an interleukin-13 (IL-13) antibody, or an antigen binding fragment, thereof.
    Type: Application
    Filed: February 3, 2023
    Publication date: July 13, 2023
    Applicant: AbbVie Inc.
    Inventors: Gregg Timony, Sheila Gujrathi, Robert Peach, Allan Olson
  • Publication number: 20230128175
    Abstract: An earthquake restraint grid framework structure includes a grid framework structure for supporting a load handling device operative to move one or more containers in a stack. The grid framework structure includes intersecting grid members arranged to form a grid having plural f substantially rectangular frames in a horizontal plane, each of the substantially rectangular frames constituting a grid cell. The grid is supported by plural upright columns at each of the intersections of grid members to form a plurality of vertical storage locations for containers to be stacked between the upright columns and be guided in a vertical direction through the substantially rectangular frames. An exoskeleton includes plural vertical frame columns braced by at least one bracing member, the grid being further supported by the exoskeleton to form a seismic restraint system (SFRS).
    Type: Application
    Filed: March 2, 2021
    Publication date: April 27, 2023
    Applicant: Ocado Innovation Limited
    Inventors: Olivier PHANEUF, Nicholas MCLARNEY, Robert PALLMANN, Allan OLSON, Scott EMMETT, Neil CARSTAIRS, Steven CRAIG, Enrique RODAL, Aditya DWIVEDI
  • Publication number: 20220281968
    Abstract: The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an interleukin-13 (IL-13) antibody, or an antigen binding fragment, thereof.
    Type: Application
    Filed: May 10, 2022
    Publication date: September 8, 2022
    Applicant: AbbVie Inc.
    Inventors: Gregg Timony, Sheila Gujrathi, Robert Peach, Allan Olson
  • Patent number: 11390669
    Abstract: The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an inter leukin-13 (IL-13) antibody, or an antigen binding fragment, thereof.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: July 19, 2022
    Assignee: Abbvie, Inc.
    Inventors: Gregg Timony, Sheila Gujrathi, Robert Peach, Allan Olson
  • Publication number: 20210380674
    Abstract: The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an inter leukin-13 (IL-13) antibody, or an antigen binding fragment, thereof.
    Type: Application
    Filed: April 27, 2017
    Publication date: December 9, 2021
    Applicant: AbbVie Inc.
    Inventors: Gregg TIMONY, Sheila GUJRATHI, Robert PEACH, Allan OLSON
  • Patent number: 9757048
    Abstract: An implantable system includes terminals, a pulse generator, a sensing circuit, separate signal processing channels, and first, second and third multiplexers. The terminals are connected to electrodes via conductors of leads. Different subsets of the electrodes are used to define different electrical pulse delivery vectors, and different subsets of the electrodes are used to define different sensing vectors. The pulse generator produces electrical pulses, and the sensing circuit senses a signal indicative of an impedance associated with a selected sensing vector. The first multiplexer selectively connects outputs of the pulse generator to a selected one of the different electrical pulse delivery vectors at a time. The second multiplexer selectively connect inputs of the sensing circuit to a selected one of the different sensing vectors at a time. The third multiplexer selectively connects an output of the sensing circuit to one of the plurality of separate signal processing channels at a time.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: September 12, 2017
    Assignee: Pacesetter, Inc.
    Inventors: Cecilia Qin Xi, Jimmy Johansson, Allan Olson, Weiqun Yang
  • Publication number: 20150282728
    Abstract: An implantable system includes terminals, a pulse generator, a sensing circuit, separate signal processing channels, and first, second and third multiplexers. The terminals are connected to electrodes via conductors of leads. Different subsets of the electrodes are used to define different electrical pulse delivery vectors, and different subsets of the electrodes are used to define different sensing vectors. The pulse generator produces electrical pulses, and the sensing circuit senses a signal indicative of an impedance associated with a selected sensing vector. The first multiplexer selectively connects outputs of the pulse generator to a selected one of the different electrical pulse delivery vectors at a time. The second multiplexer selectively connect inputs of the sensing circuit to a selected one of the different sensing vectors at a time. The third multiplexer selectively connects an output of the sensing circuit to one of the plurality of separate signal processing channels at a time.
    Type: Application
    Filed: June 23, 2015
    Publication date: October 8, 2015
    Inventors: Cecilia Qin Xi, Jimmy Johansson, Allan Olson, Weiqun Yang
  • Patent number: 9089276
    Abstract: An implantable system includes terminals, a pulse generator, a sensing circuit, separate signal processing channels, and first, second and third multiplexers. The terminals are connected to electrodes via conductors of leads. Different subsets of the electrodes are used to define different electrical pulse delivery vectors, and different subsets of the electrodes are used to define different sensing vectors. The pulse generator produces electrical pulses, and the sensing circuit senses a signal indicative of an impedance associated with a selected sensing vector. The first multiplexer selectively connects outputs of the pulse generator to a selected one of the different electrical pulse delivery vectors at a time. The second multiplexer selectively connect inputs of the sensing circuit to a selected one of the different sensing vectors at a time. The third multiplexer selectively connects an output of the sensing circuit to one of the plurality of separate signal processing channels at a time.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: July 28, 2015
    Assignee: Pacesetter, Inc.
    Inventors: Cecilia Qin Xi, Jimmy Johansson, Allan Olson, Weiqun Yang
  • Patent number: 8972010
    Abstract: The present invention generally relates to implantable medical devices, such as pacemakers, and, in particular, to a method and an implantable medical device capable of detecting the presence of noise caused by external noise sources. Voltages and/or impedances are measured over one or several electrode configurations. Based on the measured voltages and/or impedances, noise parameters are calculated, which are compared with reference values to detect the presence of noise. In another aspect of the invention, at least two different electrode configurations with different noise pick-up areas are used in the measurement. Relations between the noise parameters of the at least two vectors are calculated and compared with reference relations to detect the presence of noise.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: March 3, 2015
    Assignee: St. Jude Medical AB
    Inventors: Allan Olson, Lars Karlsson, Marcus Berner
  • Publication number: 20140276151
    Abstract: An implantable system includes terminals, a pulse generator, a sensing circuit, separate signal processing channels, and first, second and third multiplexers. The terminals are connected to electrodes via conductors of leads. Different subsets of the electrodes are used to define different electrical pulse delivery vectors, and different subsets of the electrodes are used to define different sensing vectors. The pulse generator produces electrical pulses, and the sensing circuit senses a signal indicative of an impedance associated with a selected sensing vector. The first multiplexer selectively connects outputs of the pulse generator to a selected one of the different electrical pulse delivery vectors at a time. The second multiplexer selectively connect inputs of the sensing circuit to a selected one of the different sensing vectors at a time. The third multiplexer selectively connects an output of the sensing circuit to one of the plurality of separate signal processing channels at a time.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: PACESETTER, INC.
    Inventors: Cecilia Qin Xi, Jimmy Johansson, Allan Olson, Weiqun Yang
  • Publication number: 20140027016
    Abstract: The present invention is a wood splitting apparatus that includes a trailer hitch that releasably couples the wood splitting apparatus to a vehicle, an oil reservoir that contains hydraulic oil to operate the wood splitting apparatus and a plurality of hydraulic control valves with a plurality of hydraulic hoses, where the hydraulic hoses extend from the hydraulic control valves to the oil reservoir and where the hydraulic control valves control a splitting wedge movably disposed on the second end of the wood splitting apparatus. The apparatus also includes a base table that receives a wood chunk that removably rests on the base table and a base trailer that transports the wood splitting apparatus with the vehicle.
    Type: Application
    Filed: July 29, 2012
    Publication date: January 30, 2014
    Inventor: Allan Olson
  • Publication number: 20130013011
    Abstract: A pulse generating implantable medical device comprises a power source , a control unit, a plurality of switching units, a timing unit, a pulse generating unit adapted to generate one or more stimulation pulses to be applied to human or animal tissue via one or more stimulation electrodes, and a coupling capacitor in series with each stimulation electrode. A stimulation pulse is adapted to be applied during a stimulation pulse timing cycle that includes a stimulation phase and a recharge phase, and that the timing of a stimulation pulse timing cycle is controlled by the control unit via the timing unit and the switching units. The implantable medical device further comprises an energy storage unit and that, during the recharge phase, one or more of the switching units is adapted to establish electrical connection between the one or many stimulation electrodes and the energy storage unit in order to collect and store energy from applied stimulation pulses.
    Type: Application
    Filed: March 31, 2010
    Publication date: January 10, 2013
    Applicant: ST. JUDE MEDICAL AB
    Inventors: Jorgen Edvinsson, Allan Olson, Marie Herstedt, Therese Danielsson, Ting Jun Lo
  • Publication number: 20120276268
    Abstract: Extruded, directly expanded, high fiber reduced calorie food products, such as a ready-to-eat (RTE) cereal or sweet or savory snack, are produced at high production rates without substantial loss of extrusion functionality and extrudability by replacing a substantial portion of at least one flour with a gelatinized, enzyme-resistant starch type III ingredient or bulking agent as a reduced-calorie, high fiber flour replacer. The resistant starch type III ingredient or bulking agent contains an enzyme-resistant starch type III having a melting point with an endothermic peak temperature of at least about 140° C., and may have a water-holding capacity of less than 3 grams water per gram of the starch-based bulking agent. The total dietary fiber retention of the gelatinized, starch-based bulking agent may be at least about 90% by weight after extrusion using a die temperature of least about 100° C., and a die pressure of at least about 150 psig.
    Type: Application
    Filed: April 2, 2012
    Publication date: November 1, 2012
    Applicant: KRAFT FOODS GLOBAL BRANDS LLC
    Inventors: Jeanny E. ZIMERI, Lynn HAYNES, Allan OLSON, Vijay Kumar ARORA, Louise SLADE, Harry LEVINE, Meera KWEON
  • Publication number: 20120271373
    Abstract: The present invention generally relates to implantable medical devices, such as pacemakers, and, in particular, to a method and an implantable medical device capable of detecting the presence of noise caused by external noise sources. Voltages and/or impedances are measured over one or several electrode configurations. Based on the measured voltages and/or impedances, noise parameters are calculated, which are compared with reference values to detect the presence of noise. In another aspect of the invention, at least two different electrode configurations with different noise pick-up areas are used in the measurement. Relations between the noise parameters of the at least two vectors are calculated and compared with reference relations to detect the presence of noise.
    Type: Application
    Filed: November 30, 2009
    Publication date: October 25, 2012
    Applicant: ST. JUDE MEDICAL AB
    Inventors: Allan Olson, Lars Karlsson, Marcus Berner